Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729456 | SCV000857123 | uncertain significance | not provided | 2017-10-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000729456 | SCV002287568 | uncertain significance | not provided | 2022-10-17 | criteria provided, single submitter | clinical testing | This variant, c.280_297dup, results in the insertion of 6 amino acid(s) of the POMC protein (p.Ser94_Gly99dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs10654394, gnomAD 0.1%), including at least one homozygous and/or hemizygous individual. This variant has been observed in individual(s) with extreme obesity but a second variant was not observed (PMID: 9768693). This variant is also known as the 18bp insertion between codon 73 and 74. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
New York Genome Center | RCV003227844 | SCV003925419 | uncertain significance | Obesity due to pro-opiomelanocortin deficiency; Inherited obesity | 2022-02-18 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV004559641 | SCV005049400 | uncertain significance | Inherited obesity | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000729456 | SCV005187932 | uncertain significance | not provided | criteria provided, single submitter | not provided |